SCHEDULE OF WARRANTS OUTSTANDING (Details) - Warrant [Member] - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Outstanding Number of Shares, Beginning balance | 350,000 | 350,000 | |
| Weighted Average Exercise Price, Beginning | $ 1.06 | $ 1.06 | |
| Weighted Average Remaining Contractual Terms | 6 years 25 days | 7 years 25 days | 8 years 25 days |
| Aggregate intrinsic value - Beginning | |||
| Outstanding Number of Shares, Issued | |||
| Weighted Average Exercise Price, Issued | |||
| Weighted Average Exercise Price, Exercised | $ 0 | $ 0 | |
| Outstanding Number of Shares, Expired/Forfeited | |||
| Weighted Average Exercise Price, Expired/Forfeited | |||
| Outstanding Number of Shares, Ending balance | 350,000 | 350,000 | 350,000 |
| Weighted Average Exercise Price, Ending | $ 1.06 | $ 1.06 | $ 1.06 |
| Aggregate intrinsic value - ending | |||
| Number of Shares, Vested and exercisable | |||
| Weighted Average Exercise Price, Vested and exercisable | |||
| Aggregate Intrinsic Value - Vested and exercisable | |||
| Outstanding Number of Shares, Exercised | |||
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments vested and expected to vest exercisable number. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments vested and expected to vest exercisable weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based payment award non option equity instruments forfeitures and expirations weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments aggregate intrinsic value outstanding. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments vested and expected to vest exercisable aggregate intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|